Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
-
* Corresponding author: Mirjam K Rommers m.k.rommers@lumc.nl
Critical Care 2006, 10:R93 doi:10.1186/cc4952
See related commentary by Crowthe and Lim, http://ccforum.com/10/4/150
Accesses
- Last 30 days: 59 accesses
- Last 365 days: 794 accesses
- All time: 8423 accesses